17p Deletion is associated with resistance of B-cell chronic lymphocytic leukemia cells to in vitro fludarabine-induced apoptosis

References

• Jurlander J. The cellular biology of B-cell chronic lymphocytic leukemia. Crit Rev Oncol Hematol 1998; 27: 29–52
   PubMed Web of Science ®Google Scholar
• Bannerji R, Byrd J C. Update on the biology of chronic lymphocytic leukemia. Curr Opin Oncol 2000; 12: 22–29
   PubMed Web of Science ®Google Scholar
• Jewell A P. Role of apoptosis in the pathogenesis of B-cell chronic lymphocytic leukaemia. Br J Biomed Sci 2002; 59: 235–238
   PubMedGoogle Scholar
• Osorio L M, Jondal M, Aguilar-Santelises M. Regulation of B-CLL apoptosis through membrane receptors and Bcl-2 family proteins. Leuk Lymphoma 1998; 30: 247–256
   PubMed Web of Science ®Google Scholar
• Kitada S, Andersen J, Akar S, Zapata J M, Takayama S, Krajewski S, et al. Expression of apoptosis regulating proteins in chronic lymphocytic leukemia: correlations with in vitro and in vivo chemoresponses. Blood 1998; 91: 3379–3389
   PubMed Web of Science ®Google Scholar
• Juliusson G, Merup M. Cytogenetics in chronic lymphocytic leukemia. Semin Oncol 1998; 25: 19–26
   PubMed Web of Science ®Google Scholar
• Döhner H, Stilgenbauer S, Benner A, Leupolt E, Kröber A, Bullinger L, et al. Genomic aberrations and survival in chronic lymphocytic leukemia. N Engl J Med 2000; 343: 1910–1916
   PubMed Web of Science ®Google Scholar
• Dewald G, Brockman S, Paternoster S, Bone N D, O'Fallon J R, Allmer C, et al. Chromosome anomalies detected by interphase fluorescence in hybridization: correlation with significant biological features of chronic lymphocytic leukemia. Br J Haematol 2003; 121: 287–295
   PubMed Web of Science ®Google Scholar
• el Rouby S, Thomas A, Costin D, Rosenberg C R, Potmesil M, Silber R, et al. p53 Gene mutation in B-cell chronic lymphocytic leukemia is associated with drug resistance and is independent of MDR1/MDR3 gene expression. Blood 1993; 82: 3452–3459
   PubMed Web of Science ®Google Scholar
• Döhner H, Fischer K, Bentz M, Hansen K, Benner A, Cabot G, et al. p53 Gene deletion predicts for poor survival and non-response to therapy with purine analogs in chronic B-cell lymphocytic leukemia. Blood 1995; 85: 1580–1589
   PubMed Web of Science ®Google Scholar
• Hamblin T J, Davis Z, Gardiner A, Oscier D G, Stevenson F K. Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood 1999; 94: 1848–1854
   PubMed Web of Science ®Google Scholar
• Damle R N, Wasil T, Fais F, Ghiotto F, Valetto A, Allen S L, et al. Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood 1999; 94: 1840–1847
   PubMed Web of Science ®Google Scholar
• Jelinek D F, Tschumper R C, Geyer S M, Bone N D, Dewald G W, Hanson C A, et al. Analysis of clonal B-cell CD38 and immunoglobulin variable region sequence status in relation to clinical outcome for B-chronic lymphocytic leukaemia. Br J Haematol 2001; 115: 854–861
   PubMed Web of Science ®Google Scholar
• Wiestner A, Rosenwald A, Barry T S, Wright G, Davis R E, Henrickson S E, et al. ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profile. Blood 2003; 101: 4944–4951
   PubMed Web of Science ®Google Scholar
• Burger J A, Tsukada N, Burger M, Zvaifler N J, Dell'Aquila M, Kipps T J. Blood-derived nurse-like cells protect chronic lymphocytic leukemia B cells from spontaneous apoptosis through stromal cellderived factor-1. Blood 2000; 96: 2655–2663
   PubMed Web of Science ®Google Scholar
• Bomstein Y, Yuklea M, Radnay J, Shapiro H, Afanasyev F, Yarkoni S, et al. The antiapoptotic effects of blood constituents in patients with chronic lymphocytic leukemia. Eur J Haematol 2003; 70: 290–295
   PubMed Web of Science ®Google Scholar
• Gamberale R, Geffner J, Arrosagaray G, Scolnik M, Salamone G, Trevani A, et al. Non-malignant leukocytes delay spontaneous B-CLL cell apoptosis. Leukemia 2001; 15: 1860–1867
   PubMed Web of Science ®Google Scholar
• Kay N E, Han L, Bone N, Williams G. Interleukin 4 content in chronic lymphocytic leukaemia (CLL) B cells and blood CD8+ T cells from B-CLL patients: impact on clonal B-cell apoptosis. Br J Haematol 2001; 112: 760–767
   PubMed Web of Science ®Google Scholar
• Grdisa M. Influence of CD40 ligation on survival and apoptosis of B-CLL cells in vitro. Leuk Res 2003; 27: 951–956
   PubMed Web of Science ®Google Scholar
• Moreno A, Villar M L, Camara C, Luque R, Cespon C, Gonzalez-Porque P, et al. Interleukin-6 dimers produced by endothelial cells inhibit apoptosis of B-chronic lymphocytic leukemia cells. Blood 2001; 97: 242–249
   PubMed Web of Science ®Google Scholar
• Robertson L E, Chubb S, Meyn R E, Story M, Ford R, Hittelman W N, et al. Induction of apoptotic cell death in chronic lymphocytic leukemia by 2-chloro-2′-deoxyadenosine and 9-β-d-arabinosyl-2-fluoroadenine. Blood 1993; 81: 143–150
   PubMed Web of Science ®Google Scholar
• Ricciardi M R, Petrucci M T, Gregorj C, Ariola C, Lemoli R M, Fogli M, et al. Reduced susceptibility to apoptosis correlates with kinetic quiescence in disease progression of chronic lymphocytic leukaemia. Br J Haematol 2001; 113: 391–399
   PubMed Web of Science ®Google Scholar
• Cheson B D, Bennett J M, Grever M, Kay N, Keating M J, O'Brien S, et al. National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment. Blood 1996; 87: 4990–4997
   PubMed Web of Science ®Google Scholar
• Rai K R, Sawitsky A, Cronkite E P, Chanana A D, Levy R N, Pasternack B S. Clinical staging of chronic lymphocytic leukemia. Blood 1975; 46: 219–234
   PubMed Web of Science ®Google Scholar
• Shanafelt T D, Geyer S M, Kay N E. Prognosis at diagnosis: integrating molecular biologic insights into clinical practice for patients with CLL. Blood 2004; 103: 1202–1210
   PubMed Web of Science ®Google Scholar
• Ko L J, Prives C. p53: puzzle and paradigm. Genes Dev 1996; 10: 1054–1072
   PubMed Web of Science ®Google Scholar
• Stilgenbauer S, Bullinger L, Lichter P, Dohner H. Genetics of chronic lymphocytic leukemia: genomic aberrations and V (H) gene mutation status in pathogenesis and clinical course. Leukemia 2002; 16: 993–1007
   PubMed Web of Science ®Google Scholar
• Lens D, Dyer M, Garcia-Marco J M, De Schouwer P J, Hamoudi R A, Jones D, et al. p53 Abnormalities in CLL are associated with excess of prolymphocytes and poor prognosis. Br J Haematol 1997; 99: 848–857
   PubMed Web of Science ®Google Scholar
• Gaidano G, Newcomb E W, Gong J Z, Tassi V, Neri A, Cortelezzi A, et al. Analysis of alterations of oncogenes and tumor suppressor genes in chronic lymphocytic leukemia. Am J f Pathol 1994; 144: 1312–1319
   PubMed Web of Science ®Google Scholar
• Wattel E, Preudhomme C, Hecquet B, Varumbeke M, Quesnel B, Dervite I, et al. p53 Mutations are associated with resistance to chemotherapy and short survival in hematologic malignancies. Blood 1994; 84: 3148–3157
   PubMed Web of Science ®Google Scholar
• Silber R, Degar B, Costin D, Newcornb E W, Mani M, Rosenberg C R, et al. Chemosensitivity of lymphocytes from patients with B-cell chronic lymphocytic leukemia to chlorambucil, fludarabine, and camptothecin analogs. Blood 1994; 84: 3440–3446
   PubMed Web of Science ®Google Scholar
• Johnston J B, Daeninck P, Verburg L, Lee K, Williams G, Israels L G, et al. p53, MDM-2, BAX and BCL-2 and drug resistance in chronic lymphocytic leukemia. Leuk Lymphoma 1997; 26: 435–449
   PubMed Web of Science ®Google Scholar
• Thomas A, el Rouby S, Reed J C, Krajewski S, Silber R, Potmesil M, et al. Drug-induced apoptosis in B-cell chronic lymphocytic leukemia: relationship between p53 gene mutation and bcl-2/bax proteins in drug resistance. Oncogene 1996; 12: 1055–1062
   PubMed Web of Science ®Google Scholar
• Pettitt A R, Sherrington P D, Cawley J C. The effect of p53 dysfunction on purine analogue cytotoxicity in chronic lymphocytic leukaemia. Br J Haematol 1999; 106: 1049–1051
   PubMed Web of Science ®Google Scholar
• Gartenhaus R B, Wang P, Hoffman M, Janson D, Rai K R. The induction of p53 and WAF1/CIP1 in chronic lymphocytic leukemia cells treated with 2-chlorodeoxyadenosine. J Mol Med 1996; 74: 143–147
   PubMed Web of Science ®Google Scholar
• Rosenwald A, Chuang E Y, Davis R E, Wiestner A, Alizadeh A A, Arthur D C, et al. Fludarabine treatment of patients with chronic lymphocytic leukemia induces a p53-dependent gene expression response. Blood 2004; 104: 1428–1434
   PubMed Web of Science ®Google Scholar
• Pettitt A R, Clarke A R, Cawley J C, Griffiths S D. Purine analogues kill resting lymphocytes by p53-dependent and -independent mechanisms. Br J Haematol 1999; 105: 986–988
   PubMed Web of Science ®Google Scholar
• Pettitt A R. Mechanism of action of purine analogues in chronic lymphocytic leukaemia. Br J Haematol 2003; 121: 692–702
   PubMed Web of Science ®Google Scholar
• Gross A, McDonnell J M, Korsmeyer S. Bcl-2 family members and the mitochondria in apoptosis. Genes Dev 1999; 13: 1899–1911
   PubMed Web of Science ®Google Scholar
• Hanada M, Delia D, Aiello A, Stadtmauer E, Reed J C. Bcl-2 gene hypomethylation and high-level expression in B-CLL chronic lymphocytic leukemia. Blood 1993; 82: 1820–1828
   PubMed Web of Science ®Google Scholar
• Robertson L E, Plunkett W, McConnell K, Keating M J, Mc-Donnell T J. Bcl-2 expression in chronic lymphocytic leukemia and its correlation with induction of apoptosis and clinical outcome. Leukemia 1996; 10: 456–459
   PubMed Web of Science ®Google Scholar
• Consoli U, El-Tounsi I, Sandoval A, Snell V, Kleine H D, Brown W, et al. Differential induction of apoptosis by fludarabine monophosphate in leukemic B and normal T cells in chronic lymphocytic leukemia. Blood 1998; 91: 1742–1748
   PubMed Web of Science ®Google Scholar
• Miyashita T, Harigai M, Hanada M, Reed J C. Identification of a p53-dependent negative response element in the bcl-2 gene. Cancer Res 1994; 54: 3131–3135
   PubMed Web of Science ®Google Scholar
• Lomo J, Smeland E B, Krajewski S, Reed J C, Blomhoff H K. Expression of the bcl-2 homologue Mcl-1 correlates with survival of peripheral blood B lymphocytes. Cancer Res 1996; 56: 40–43
   PubMed Web of Science ®Google Scholar
• Johnston J B, Paul J T, Neufeld N J, Haney N, Kropp D M, Hu X, et al. Role of myeloid cell factor-1 (Mcl-1) in chronic lymphocytic leukemia. Leuk Lymphoma 2004; 45: 2017–2027
   PubMed Web of Science ®Google Scholar
• Lin K, Sherrington P D, Dennis M, Matrai Z, Cawley J C, Pettitt A R. Relationship between p53 dysfunction, CD38 expression, and IgVH mutation in chronic lymphocytic leukemia. Blood 2002; 100: 1404–1409
   PubMed Web of Science ®Google Scholar
• Zupo S, Isnardi L, Megna M, Massara R, Malavasi F, Dono M, et al. CD38 expression distinguishes 2 groups of B-chronic lymphocytic leukemias with different responses to anti-IgM antibodies and propensity to apoptosis. Blood 1996; 88: 1365–1374
   PubMed Web of Science ®Google Scholar
• Deaglio S, Capobianco A, Bergui L, Durig J, Morabito F, Duhrsen U, Malavasi F. CD38 is a signaling molecule in B-cell chronic lymphocytic leukemia cells. Blood 2003; 102: 2146–2155
   PubMed Web of Science ®Google Scholar